Clinical development programs continue to face growing complexity, longer timelines, and increasing pressure to deliver therapies to patients faster.

This white paper explores how a predictive approach can help sponsors make more informed decisions earlier, reduce uncertainty, prevent avoidable delays, and accelerate development through the combination of real-world data, predictive analytics, AI, automation, and deep therapeutic and operational expertise.

Drawing on decades of experience leading clinical research transformation and global development operations, this paper provides a practical framework for unlocking measurable gains in speed, efficiency, and commercial value across the clinical development lifecycle.

Authored by Brian O'Dwyer, President of Global Clinical Development, and Cyndi Verst, PharmD, MS, President of Design and Delivery Innovation.